pipette
ESEspañol

SMCHD1 is a target for gene activation therapy to treat Prader-Willi syndrome

Megan Iminitoff, Anna K. Le Fevre, Tamara J Beck, Hannah Kate Vanyai, Caleb Chew, Sarah Kinkel, Kelsey A. Breslin, Susanne Theiß, Quentin A. Gouil, Merlin Thomas, James M. Murphy, Christian P. Schaaf, Andrew Keniry, Marnie E. Blewitt

Peer-reviewed journalBold claims, read criticallyReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
Deleting Smchd1 after early development in vivo activated PWS genes in disease-relevant mouse tissues including hypothalamus and improved phenotypes in a PWS mouse model.

Appeared: Sunday, October 11. Science Advances. Peer-reviewed journal.

DOI: 10.1126/sciadv.aej5702